Google DeepMind launched AlphaGenome, an AI tool that predicts how DNA mutations drive disease.
The system analyses up to one million DNA letters at once.
AlphaGenome shows how mutations alter gene control across different cells and tissues.
Researchers trained the model using human and mouse genetics databases.
Scientists say it could speed up discovery of cancer drivers and inherited disorders.
Experts believe the tool may also support future gene and precision therapies.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
Add A Comment
© 2025 Health And Care Mag. All Rights Reserved.